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Cell apoptosisPAX6 contributes to the development and progression of retinoblastoma (RB), but the molecular
mechanism underlying the regulation of PAX6 expression is unclear. Here we found that microR-
NA-365b-3p (miR-365b-3p) is downregulated in human RB tissues. Ectopic expression of miR-
365b-3p signiﬁcantly attenuates cell growth, induces cell cycle arrest in G1 phase and cell apoptosis
through inhibiting the expression of PAX6 by directly binding its 30 untranslated regions. Further-
more, overexpression of miR-365b-3p upregulates p21 and p27 but downregulates cdc2 and Cyclin
D1 protein levels. Elucidating the regulatory mechanism of PAX6 by microRNAs may give new clues
to the therapy against RB.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction cancers through acting as potent oncogenes or tumor suppressorRetinoblastoma (RB) is the most common malignant intraocular
tumor in childhood [1]. It affects approximately 1:14000 to
1:22000 live births [2]. Accumulating data showed that genetic
or epigenetic alterations in a large number of oncogenes and tumor
suppressor genes, such as the inactivation of Rb1 gene, are in-
volved in development of RB [2]. PAX6 has also been reported to
be a key regulator in the embryological development of the retina
and correlate with the development and progression of RB [3,4].
However, the underlying molecular mechanisms that regulate
the expression of PAX6 are still poorly understood.
MicroRNAs (miRNAs), a class of endogenous, small (22 nt)
non-coding RNAs, bind the 30 untranslated regions (UTRs) of their
target mRNAs and induce mRNA degradation or translational
repression, thus inﬂuencing many physiological and pathological
process, such as differentiation, proliferation, metabolism, and
death [5]. Also, accumulating data suggests that miRNAs are
frequently dysregulated and play critical roles in various types ofgenes [6].
In the present study, we focused on the expression regulation of
PAX6 by miRNAs and the function of the candidate miRNAs.
Through these studies, microRNA-365b-3p (miR-365b-3p), down-
regulated in RB tissues, was identiﬁed to inhibit the expression
of PAX6 directly and functioned as a tumor suppressor through
inducing cell cycle arrest and cell apoptosis.
2. Materials and methods
2.1. Human tissue samples and cell lines
Six human RB tissues and two normal retina tissues were pro-
vided by the Center of Ophthalmology and Otorhinolaryngology,
the Fourth Afﬁliated Hospital, Harbin Medical University. The hu-
man RB cell lines (Y79, WERI-RB-1, and SO-RB50) were from ATCC
and cultured in RPMI1640 medium (GIBCO) supplemented with
10% heat-inactivated FBS, 100 U/l penicillin, and 100 U/l strepto-
mycin in a humidiﬁed atmosphere of 95% air and 5% CO2 at 37 C.
2.2. Prediction of miRNAs targeting PAX6
MiRNAs targeting the 30UTR of PAX6 mRNA (NM_000280) was
predicted by TargetScan and www.microRNA.org database, and
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date miRNAs.
2.3. MiRNA transfection experiments
For transfection experiments, 3  105 cells were seeded at 6-cm
dish in antibiotic-free RPMI1640 with 10% FBS. 24 h later, the spe-
ciﬁc mimics of miRNAs and control oligo were transfected into
cells with Lipofectamine 2000 (invitrogen, CA, USA) following the
manufacturer’s instruction. The mimic of speciﬁc miRNA was du-
plex RNA, in which the sense sequence was the same as miRNA it-
self, and the antisense sequence had 2-nt 30-overhangs and 2-nt 50-
trims. The detail sequence of miRNAmimics were shown in Table 1.
The non-targeting sequence (control mimic) was used as negative
control. All the above mentioned RNAs were commercially synthe-
sized by RiboBio (Guangzhou, China).
2.4. Western blot analysis
To extract the total proteins, cultured cells were lysed by RIPA
buffer (Beyotime, Jiangsu, China) and then the lysates were centri-
fuged at 14000 rpm for 10 min to remove the cell debris. The clin-
ical tissues were lysed by TRI Reagent (Sigma–Aldrich, St. Louis,
MO, USA) and extracted by chloroform. Then proteins were precip-
itated from the phenol–ethanol supernatant with isopropanol and
washed three times in a solution containing 0.3 M guanidine
hydrochloride in 95% ethanol. Finally, perform the ﬁnal wash in
100% ethanol, dry the pellet and solubilize it with 1% SDS. To per-
form Western blot, the protein extracts were fractionated by 8–
12% SDS–PAGE gel and then transferred to nitrocellulose mem-
branes. The membranes were probed with the rabbit anti-PAX6,
anti-cyclin D1 and anti-GAPDH antibodies (Santa Cruz, CA, USA),
and the rabbit anti-P21, anti-P27 and anti-cyclin D1 antibodies
(Cell Signaling Technologies, Beverly, MA, USA), followed by the
HRP-conjugated goat anti-rabbit IgG antibody as secondaryTable 1
The sequences of miRNA mimics used in the experiments.
MiRNA mimic Sense sequence (50–30)
MiR-7 mimic UGGAAGACUAGUGAUUU
MiR-365b-3p mimic UAAUGCCCCUAAAAAUCC
miR-129-5p mimic CUUUUUGCGGUCUGGGCU
MiR-206 mimic UGGAAUGUAAGGAAGUG
MiR-1 mimic UGGAAUGUAAAGAAGUAU
Control mimic UUCUCCGAACGUGUCACG
Table 2
The probes and primers used in the experiments.
Name Sequence (50–30)
MiR-365b-3p probe ATAAGGATTTTTAGG
U6 probe AGATTAGCATGGCCC
MiR-7-RT primer GTCGTATCCAGTGCA
MiR-7-Fwd TGGAAGACTAGTGAT
MiR-365b-3p-RT primer GTCGTATCCAGTGCA
MiR-365b-3p-Fwd TAATGCCCCTAAAAA
MiR-129-5p-RT primer GTCGTATCCAGTGCA
MiR-129-5p-Fwd CTTTTTGCGGTCTGG
MiR-206-RT primer GTCGTATCCAGTGCA
MiR-206-Fwd TGGAATGTAAGGAAG
MiR-1-RT primer GTCGTATCCAGTGCA
MiR-1-Fwd TGGAATGTAAAGAAG
U6-RT primer GTCGTATCCAGTGCA
U6-Fwd TGCGGGTGCTCGCTT
Rev CCAGTGCAGGGTCCGantibody. QuantityOne sofeware was used to analyze and quantify
the expression of interest proteins.
2.5. RNA preparation and Northern blot analysis
Total RNAs from retina tissues and cells were extracted using
TRI Reagent. 2 lg of total RNA from retina tissues was fractionated
on a denaturing 12% polyacrylamide gel containing 8 M urea,
transferred to Nytran N membrane (Schleicher & Schuell, Ger-
many) and ﬁxed by ultraviolet cross-linking. DNA oligonucleotide
probe complementary to mature miR-365b-3p (miR-365b-3p
probe, Table 2) was synthesized by GenePharma (Shanghai, China)
and end-labelled with 32P-ATP by using T4 polynucleotide kinase.
Then membranes were probed with the above 32P-labelled probes
as described previously [7]. U6 snRNAwas used for loading control.
2.6. qRT-PCR
Brieﬂy, 2 lg of total RNA was reverse transcribed to cDNA using
M-MLV reverse transcriptase (Promega, Madison, WI, USA) with
the speciﬁc stem-loop RT primer. Then qPCR was performed using
miRNA speciﬁc forward primers (Fwd) and the universal reverse
primer (Rev) as described in the method of SYBR premix Ex Taq
(TaKaRa) with Applied Rotor-Gene 6000 Real Time PCR System
(Corbett Research). U6 snRNA levels were used for normalization.
All reactions were performed in triplicate. The fold-change for gene
expression was calculated using 2DDCt. The primers used were
shown in Table 2.
2.7. Plasmid construction
The full-length human PAX6 CDS sequence was obtained from
the cDNA of Y79 cells by PCR method using the following primers:
50-CGCTAAGCTTCAGAACAGTCACAGCGGAGTG-30; and 50-GTACCTC
TAGACTGTAATCTTGGCCAGTATTG-30. Then the 1287 bp fragmentAntisense sequence (50–30)
UGUUGU AACAAAAUCACUAGUCUUCCATT
UUAU AAGGAUUUUUAGGGGCAUUATT
UGC AAGCCCAGACCGCAAAAAGTT
UGUGG ACACACUUCCUUACAUUCCATT
GUAU ACAUACUUCUUUACAUUCCATT
UTT ACGUGACACGUUCGGAGAATT
GGCATTA
CTGCGCAA
GGGTCCGAGGTGCACTGGATACGACACAACT
T
GGGTCCGAGGTGCACTGGATACGACATAAGG
T
GGGTCCGAGGTGCACTGGATACGACGCAAGC
GGGTCCGAGGTGCACTGGATACGACCCACAC
T
GGGTCCGAGGTGCACTGGATACGACATACAT
GGGTCCGAGGTGCACTGGATACGACAAAATATGG
CGGCAGC
AGGT
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ly, the resulting construct pcDNA3/PAX6 was conﬁrmed by DNA
sequencing.
2.8. Enhanced green ﬂuorescent protein (EGFP) reporter assays
The 30UTR fragments of PAX6 located in the 2002–2201 nt of
the mRNA of PAX6, containing the putative miR-365b-3p binding
site and its mutant binding sites (UUACGGG?AUUCCGC), were
synthesized commercially by GenePharma (Shanghai, China) and
inserted into the EGFP reporter vector pcDNA3/EGFP (constructed
as described [8]) with BamH I and EcoR I sites. Both of the two in-
serts were conﬁrmed by DNA sequencing. The vector pDsRed2-N1
expressing red ﬂuorescent protein (RFP) was used for
normalization.
For EGFP reporter experiments, cells were seeded on 24-well
plates and co-transfected with each EGFP reporter construct
(0.5 lg) and miR-365b-3p mimics (100 pmol), along with pDs-
Red2-N1 vector (0.05 lg). And control mimic RNAwas used as neg-
ative control. 48 h later, cells were lysed with RIPA buffer
(Beyotime, China) and the ﬂuorescence intensities of EGFP and
RFP ﬂuorescence were detected with a Fluorescence Spectropho-
tometer F-4500 (HITACHI). Each experiment was repeated at least
three times.
2.9. Cell viability assay
Cells were plated in 96-well plates (0.5  104 cells per well) and
transfected with miR-365b-3p mimic and control mimic. In addi-
tion, we also cotransfected miR-365b-3p mimic and either
pcDNA3/PAX6 or pcDNA3 into the cells. 48 h later, 10 ll of MTT re-
agent (5 mg/ml) was added to each well and cells were incubated
at 37 C for another 4 h. Absorbance was read at 570 nm with a
Bio-Rad microplate reader (Hercules, CA, USA).
2.10. Colony formation assay
Cells were seeded onto 24 well plate (200 cells per well) in trip-
licate, respectively. Then cell culture medium was replaced every
3 days. 10 days after seeding, cell colonies which contained more
than 50 cells were counted and stained with crystal violet.
2.11. Flow cytometry analysis of cell cycle and cell apoptosis
The RB cells were transfected with miR-365b-3p mimic or con-
trol mimic alone, or a combination of miR-365b-3p mimic and
pcDNA3/PAX6 or pcDNA3. 48 h post-transfection, cells were tryp-
sinized and analyzed for cell cycle distribution and cell apoptosis.
For cell cycle distribution, half of the cells of each group was
stained with propidium Iodide (PI) and analyzed by ﬂow cytometry
using FACSCalibur (BD Biosciences, San Diego, CA, USA). For each
group, 10000 events were acquired. The percentage of cells in
G0/G1, S and G2/M phases of the cell cycle was calculated. The
other half of cells of each group was used to detect the cell apop-
tosis using APC (allophycocyanin)-annexin V and 7-AAD (7-amin-
oactinomycin D) staining kit (Tianjin Sungene) following the
manufacturer’s instructions.
2.12. In vivo tumorigenesis assay
Athymic BALB/c nude mice (6–7 weeks old) were randomly as-
signed to one of two groups (six mice per group). MiR-365b-3p mi-
mic and control mimic were transfected into Y79 cells. 48 h after
transfection, cells were trypsinized and resuspended at a ﬁnal con-
centration of 1  106 cells/0.1 ml in PBS. Cells were injected subcu-
taneously in the right ﬂank of the nude mice. Tumor growth wasmonitored and recorded by measuring tumor length and width
every other day, and tumor volume was calculated according to
1/2  length width2. Mice were sacriﬁced 2 weeks later for
evaluation.
2.13. Statistical analysis
All the data were expressed as the means ± S.D. and analyzed
with two-way ANOVA. Additionally, data from EGFP reporter as-
says or the expression of PAX6 and miR-365b-3p in human RB cells
or tissues were analyzed with one-way ANOVA or Student’s t-test.
Each experiment was performed at least three times. Differences
were considered statistically signiﬁcant at P < 0.05.
3. Results
3.1. Regulatory role of miR-365b-3p on the expression of PAX6 and its
expression proﬁle in retina tissues
In order to investigate the regulation of PAX6 by miRNAs, we
predicted the miRNAs which can potentially target the 30UTR of
PAX mRNA using bioinformatic methods. As shown in Fig. 1A,
miR-7, miR-365b-3p, miR-129-5p, miR-206 and miR-1 were found
to have binding sites in the 30UTR of PAX6. Then speciﬁc miRNA
mimics were employed to enhance the expression level of the
above mentioned miRNA in three RB cell lines, Y79, SO-RB50 and
WERI-RB-1. Firstly, we veriﬁed that the individual miRNA mimic
can obviously enhance the level of miRNAs comparing to control
mimic determined by qRT-PCR (Fig. 1B). Then the protein level of
PAX6 was detected to reﬂect the inﬂuence of speciﬁc miRNA on
PAX6. As shown in Fig. 1C, both miR-7 and miR-365b-3p can signif-
icantly inhibit the expression of PAX6 protein, and miR-365b-3p
has the most obvious inhibitory effects on the protein level of
PAX6 in three cell lines (Fig. 1C and D).
We further examined whether PAX6 was regulated by miR-
365b-3p directly. It has been predicted that miR-365b-3p has
one potential binding site on the 30UTR of PAX6 which was con-
served between human, mouse and rat mRNA (Fig. 2A). The EGFP
reporter with wild-type PAX6 30UTR (WT-30UTR) or its mutant type
(MUT-30UTR) were transfected with miR-365b-3p mimic or control
mimic into the above mentioned RB cell lines. As shown in Fig. 2B–
D, transfection of miR-365b-3p mimic in three RB cell lines with
WT-30UTR had a signiﬁcant decrease of EGFP intensity compared
with control mimic (P < 0.05). However, transfection of miR-
365b-3p mimic with MUT-30UTR showed no effect on EGFP inten-
sity compared with control group (P > 0.05). Moreover, we also
showed that the levels of miR-365b-3p determined by Northern
blot analysis were obviously lower, whereas the protein levels of
PAX6 detected by Western blot analysis were signiﬁcantly higher
in RB tissues than those in normal retinal tissues (Fig. 2E–H). Taken
together, these results demonstrated that miR-365b-3p was down-
regulated in RB tissues and directly inhibits PAX6 protein
expression.
3.2. Effects of miR-365b-3p on cell growth and proliferation of human
RB cell lines in vitro and in vivo
Since PAX6 has been reported to enhance the cell growth and
proliferation of human RB cell lines [3], we want to investigate
whether miR-365b-3p has the opposite effects through inhibiting
PAX6. To conﬁrm this possibility, we increased the miR-365b-3p
level in human RB cells with miR-365b-3p mimic, and rescued
the expression of PAX6 on the basis of miR-365b-3p mimic trans-
fection, then detected the cell growth and proliferation by MTT
assays and colony formation assays. First, Western blot analysis
showed that miR-365b-3p mimic signiﬁcantly inhibited the
Fig. 1. Screening the miRNAs that have potential binding sites on the 30UTR of PAX6 mRNA. (A). Schematic representation of the interaction between miRNAs and the 30UTR
of PAX6. (B–D) Speciﬁc miRNA mimics corresponding to miR-7, miR-365, miR-129-5p, miR-206 and miR-1 were transfected into Y79, SO-RB50 and WERI-RB-1 cells,
respectively with control mimic as negative control. 48 h later, the expression of respective miRNA was determined by qRT-PCR (B). Meanwhile, PAX6 protein (47 kDa) was
detected by Western blot analysis (C). Glyceraldehyde phosphate dehydrogenase (GAPDH) (34 kDa) was used as an internal control and the relative PAX6 protein quantity is
shown (D). ⁄⁄P < 0.01, compared with the control mimic group.
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three cell lines, while the overexpression vector of PAX6,
pcDNA3/PAX6, abolished the inhibited PAX6 expression of PAX6
caused by miR-365b-3p mimic (Fig. 3A). Then MTT and colony for-
mation assays showed that miR-365b-3p inhibited cell viability
and cell proliferation, while PAX6 expression vector can rescue
the inhibitory effects caused by gain of function of miR-365b-3p
(Fig. 3B and C).
Moreover, we investigate the effects of miR-365b-3p on growth
of Y79 cells in vivo. As shown in Fig. 4A and B, mice injected Y79
cells with a high level of miR-365b-3p had much smaller tumor
volumes than that in control group. And the expression level of
miR-365b-3p in tumor tissues with miR-365b-3p mimic transfec-
tion group is higher, whereas the expression level of PAX6 is lower
than that in tumor tissues with control mimic transfection group
(Fig. 4C). These data suggested that enforced expression of miR-
365b-3p can signiﬁcantly suppressed human RB cell growth by
inhibiting PAX6 protein level and functions as a tumor suppressor
in vitro and in vivo.
3.3. Effects of miR-365b-3p on cell cycle and apoptosis of human RB
cell lines
To further investigate the mechanism of miR-365b-3p-induced
cell growth inhibition, we assessed the change of the cell cycle dis-
tribution by ﬂow cytometry. In three RB cell lines Y79, SO-Rb50
and WERI-RB-1, miR-365b-3p mimic signiﬁcantly decreased the
percentages of cells in the S-phase, whereas increased that in the
G0/G1-phase comparing to the control mimic transfected cells,
suggesting miR-365b-3p can induce G1 arrest (Fig. 5A–C). And
over-expression of PAX6 can reverse the effects of miR-365b-3pon the cell cycle distribution of RB cells (Fig. 5A–C). We further
found the level of P21 and P27 protein was up-regulated, whereas
the level of cdc2 and Cyclin D1 was down-regulated in the cell
transfected with miR-365b-3p in comparison to cells transfected
with control mimic, and PAX6 expression can reverse the change
of the above molecular caused by miR-365b-3p over-expression
(Fig. 5D–F). Thus, over-expression of miR-365b-3p could lead to
G1 arrest which is correlated with up-regulation of P21 and P27
and down-regulation of cdc2 and Cyclin D1.
We also evaluated the effects of miR-365b-3p on the cell apop-
tosis of three RB cell lines. As shown by Fig. 6, miR-365b-3p over-
expression can signiﬁcantly increase the percentage of apoptotic
cells, while the expression of PAX6 can counteract the promotion
of apoptosis caused by miR-365b-3p expression at least in part.
4. Discussion
Paired homeobox protein PAX6 is a member of the PAX gene
family and encodes a highly conserved transcriptional factor in
both ﬂies and mammals. It has been evident that PAX6 gene is ac-
tively involved in the development of the eye [9,10] and plays a key
role in the development and progression of a variety of different
cancers, including RB [3,11–13]. Recently, accumulating evidence
suggests a vital role for miRNAs in human carcinogenesis through
targeting tumor suppressors or oncogenes [6]. PAX6 has been re-
ported to be regulated by miR-328 [14] and miR-7a [15], thus in-
volved in myopia development and controlled spatial origin of
forebrain dopaminergic neurons. Here, we demonstrated that
miR-365b-3p negatively regulated PAX6 protein expression and
attenuated cell growth in RB cells through inhibiting cell cycle
and inducing cell apoptosis. And all of the effects of miR-365b-3p
Fig. 2. PAX6 is a direct target gene of miR-365. (A) The 30UTR of PAX6 has a putative binding site of miR-365b-3p that is conserved among human, mouse and rat. The
putative miR-365b-3p targeted sequences in the wild-type or mutated 30UTR of PAX6 are shown. Yellow background: non-conserved bases. (B–D) The EGFP reporter vectors
carrying the wild-type or mutated 30UTR of PAX6 were transfected into Y79 cells along with miR-365b-3p mimic or control mimic. RFP expression vector was used as a
normalizer. The intensity of EGFP ﬂuorescence was monitored at 48 h after transfection. All experiments were performed three times. Similar results were obtained in SO-
RB50 (C) and WERI-RB-1 (D) cells. (E–H) Northern bolt or Western blot analysis were used to investigate the expression of miR-365b-3p (E) or PAX6 protein (G) in retinal
tissues with U6 snRNA or GAPDH as endogenous control. The relative expression was shown (F and H). N, normal retina tissues; R, RB tissues; all N: the average expression
level of all normal retina tissues; all R: the average expression level of RB tissues. ⁄⁄P < 0.01; #P > 0.05.
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These results supported a previous study which showed that
silencing of PAX6 by siRNA can inhibit the cell growth of RB cells
and cause inhibited cell cycle progression and increased cell apop-
tosis [3]. Nie et al. also reported that miR-365b-3p was down-reg-
ulated in colon cancer and resulted in inhibiting cell cycle
progression and promoting apoptosis [16], suggesting that miR-
365b-3p may function as a tumor suppressor gene in colon cancer
and RB cells at least.
Moreover, we also investigated the potential mechanism of
miR-365b-3p on cell cycle distribution and found that high levels
of miR-365b-3p lead to the up-regulation of the P21 and P27 pro-
teins and the down-regulation of cdc2 and CyclinD1, thus inducing
cell cycle arrest. Cell cycle was regulated by the expression of cyc-
lins and sets of activating and inhibitory proteins. According toprevious studies, P27 protein is a major player in the G0/G1 check-
point and blocked the cell cycle transition from G1- to S-phase.
And P21 protein mediates both G0/G1 and G2/M arrest [17]. The
cdc2 protein is responsible for G2/M arrest and cyclinD1 is essen-
tial for the progression through the cell cycle [17–19]. Thus the in-
creased levels of P21 and P27 and the decreased levels of cdc2 and
cyclin D1 in response to miR-365b-3p can explain the cell cycle ar-
rest. Silencing of PAX6 has been reported to up-regulate P21 and
P27 proteins and down-regulate cdc2 protein, but have no effects
on cyclin D1 expression [3]. However, we showed that miR-
365b-3p not only regulated the expression of P21, P27 and cdc2
through targeting PAX6, but also caused the down-regulation of
cyclin D1 which can be abolished by PAX6 partly, which may be
explained by another study in which they reported that miR-
365b-3p may target Cyclin D1 and inhibit its expression [16]. But
Fig. 3. MiR-365b-3p inhibits the growth and proliferation of human RB cells by targeting PAX6. MiR-365b-3p mimic, control mimic, or miR-365b-3p mimic along with
pcDNA3/PAX6 or pcDNA3 was transfected into three RB cells, respectively. (A) Western blot analysis was used to detect the expression of PAX6 protein (47 kDa) and GAPDH
(34 kDa) were used for normalizer. (B) MTT assays were used to assess cell viability and control mimic transfected group was set as 100%. Values are means ± S.D. of three
independent assays. (C and D) Cell colony formation assays were used to assess the capacity of cell proliferation. Cell colonies were stained with 2% crystal violet and
representative photos are shown (C). Data are presented as the means ± S.D. from three independent experiments (D). ⁄P < 0.05; ⁄⁄P < 0.01.
Fig. 4. Ectopic expression of miR-365b-3p inhibits cell growth of Y79 cell in vivo. (A and B) miR-365b-3p mimic or control mimic was transfected into Y79 cells respectively
for 48 h. Then cells were injected subcutaneously in the right ﬂank of the nude mice (n = 6 per group). Tumor growth was monitored by measuring tumor length and width.
Gross morphology of overall tumor was shown. (C) MiR-365b-3p and PAX6 protein (47 kDa) expression levels in tumor tissues were assessed by qRT-PCR with U6 snRNA as
an internal control or Western blot analysis with GAPDH (34 kDa) for normalization. The representative image and the relative expression level were shown. ⁄⁄P < 0.01.
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Fig. 5. Ectopic expression of miR-365b-3p results in G1-phase arrest. (A–C) miR-365b-3p mimic, control mimic, or miR-365b-3p mimic along with pcDNA3/PAX6 or pcDNA3
was transfected into three RB cells, respectively and cell cycle was assessed by PI staining and FACS. The distribution of the cell cycle-phase was expressed as the percentage
of cells in the G0/G1-phase, S-phase, and G2/M-phase of the cell cycle. Control mimic transfected cells were used as negative control group. Distribution of the cell cycles for
the human RB cell lines Y79 (A), SO-RB50 (B) and WERI-RB-1 (C) cells are shown. All the experiments were performed three times in triplicate. (D–F) Western blot analysis
was used to evaluate the expression of cell cycle related protein, P21 (21 kDa), P27 (27 kDa), cdc2 (34 kDa) and cyclinD1 (36 kDa) in Y79 (D), SO-RB50 (E) and WERI-RB-1 (F)
cells in the above four groups and the relative expression were shown. GAPDH (34 kDa) was used for normalization. ⁄P < 0.05; ⁄⁄P < 0.01; #P > 0.05.
Fig. 6. MiR-365b-3p induces cell apoptosis in human RB cells. Cell apoptosis of Y79, SO-RB50 and WERI-RB-1 cells transfected with miR-365b-3p mimic, control mimic or
miR-365b-3p mimic along with pcDNA3/PAX6 or pcDNA3 were assessed by annexin V and 7-AAD staining followed by ﬂow cytometry analysis. Results are means ± S.D. from
three independent experiments. ⁄⁄P < 0.01.
J. Wang et al. / FEBS Letters 587 (2013) 1779–1786 1785how the over-expression of PAX6 counteract the down-regulation
of cyclin D1 caused by enforced expression of miR-365b-3p re-
mained unclear and needed further investigation.
In summary, we showed that miR-365b-3p was down-regu-
lated in RB tissues and ectopic expression of miR-365b-3p cansigniﬁcantly reduce cell growth and proliferation in RB cells
through targeting PAX6, which was related with increased G1
phase arrest and cell apoptosis. Moreover, the altered cell cycle dis-
tribution is in association with the up-regulation of P21 and P27
protein and the down-regulation of cdc2 and Cyclin D1 protein.
1786 J. Wang et al. / FEBS Letters 587 (2013) 1779–1786These results suggested that miR-365b-3p played a role in inhibit-
ing the development and progression of RB by inhibiting PAX6 and
may potentially lead to a novel strategy of therapy to RB.
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